Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-alpha-phellandrene | decreases expression | EXP | | 6480464 | alpha phellandrene results in decreased expression of CR1L mRNA | CTD | PMID:25075043 | 1,2-dimethylhydrazine | multiple interactions | ISO | Cr1l (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CR1L mRNA | CTD | PMID:22206623 | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Cr1l (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:24680724 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Cr1l (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CR1L mRNA | CTD | PMID:19770486 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CR1L mRNA | CTD | PMID:32109520 and PMID:34747641 | 2,6-dinitrotoluene | affects expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of CR1L mRNA | CTD | PMID:21346803 | 2-nitrofluorene | increases expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | 2-nitrofluorene results in increased expression of CR1L mRNA | CTD | PMID:15890375 and PMID:22484513 | 4,4'-diaminodiphenylmethane | affects expression | ISO | Cr1l (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane affects the expression of CR1L mRNA | CTD | PMID:18648102 | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CR1L mRNA | CTD | PMID:15890375 | acetamide | increases expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | acetamide results in increased expression of CR1L mRNA | CTD | PMID:31881176 | aconitine | increases expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | Aconitine results in increased expression of CR1L protein | CTD | PMID:33236894 | acrylamide | affects expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | Acrylamide affects the expression of CR1L mRNA | CTD | PMID:28959563 | aflatoxin B1 | decreases expression | ISO | Cr1l (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of CR1L mRNA | CTD | PMID:19770486 | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of CR1L intron | CTD | PMID:30157460 | aflatoxin B1 | increases expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | Aflatoxin B1 results in increased expression of CR1L mRNA | CTD | PMID:15890375 more ... | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CR1L mRNA | CTD | PMID:33167477 | alpha-phellandrene | decreases expression | EXP | | 6480464 | alpha phellandrene results in decreased expression of CR1L mRNA | CTD | PMID:25075043 | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of CR1L mRNA | CTD | PMID:24449571 | belinostat | increases expression | EXP | | 6480464 | belinostat results in increased expression of CR1L mRNA | CTD | PMID:26272509 | belinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CR1L mRNA | CTD | PMID:27188386 | benzo[a]pyrene | increases expression | ISO | Cr1l (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CR1L mRNA | CTD | PMID:22228805 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of CR1L promoter | CTD | PMID:27901495 | bisphenol A | increases expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of CR1L mRNA | CTD | PMID:25181051 and PMID:31771501 | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of CR1L gene | CTD | PMID:31601247 | bisphenol A | decreases expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of CR1L mRNA | CTD | PMID:30816183 | cadmium dichloride | decreases expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased expression of CR1L mRNA | CTD | PMID:33453195 | clofibrate | multiple interactions | ISO | Cr1l (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of CR1L mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CR1L mRNA] | CTD | PMID:17585979 | clofibrate | increases expression | ISO | Cr1l (Mus musculus) | 6480464 | Clofibrate results in increased expression of CR1L mRNA | CTD | PMID:17585979 | clofibric acid | affects expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | Clofibric Acid affects the expression of CR1L mRNA | CTD | PMID:17602206 | crocidolite asbestos | decreases expression | ISO | Cr1l (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of CR1L mRNA | CTD | PMID:29279043 | diclofenac | multiple interactions | ISO | Cr1l (Rattus norvegicus) | 6480464 | [Water deficiency co-treated with Diclofenac] results in decreased expression of CR1L protein and Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in decreased expression of CR1L protein] | CTD | PMID:31042592 | diethylstilbestrol | increases expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | Diethylstilbestrol results in increased expression of CR1L mRNA | CTD | PMID:15890375 | diprotium oxide | multiple interactions | ISO | Cr1l (Rattus norvegicus) | 6480464 | [Water deficiency co-treated with Diclofenac] results in decreased expression of CR1L protein and Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in decreased expression of CR1L protein] | CTD | PMID:31042592 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | endosulfan | decreases expression | ISO | Cr1l (Mus musculus) | 6480464 | Endosulfan results in decreased expression of CR1L mRNA | CTD | PMID:23208437 and PMID:25242399 | endosulfan | decreases expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of CR1L mRNA | CTD | PMID:29391264 | endosulfan | multiple interactions | ISO | Cr1l (Mus musculus) | 6480464 | Testosterone Propionate inhibits the reaction [Endosulfan results in decreased expression of CR1L mRNA] and Vitamin E inhibits the reaction [Endosulfan results in decreased expression of CR1L mRNA] | CTD | PMID:23208437 and PMID:25242399 | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CR1L mRNA | CTD | PMID:27188386 | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of CR1L mRNA | CTD | PMID:26272509 | folic acid | multiple interactions | ISO | Cr1l (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CR1L mRNA | CTD | PMID:22206623 | gentamycin | increases expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of CR1L mRNA | CTD | PMID:22061828 | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of CR1L mRNA | CTD | PMID:35811015 | lipopolysaccharide | multiple interactions | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CR1L mRNA] | CTD | PMID:35811015 | methapyrilene | increases expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | Methapyrilene results in increased expression of CR1L mRNA | CTD | PMID:15890375 | N-nitrosodimethylamine | increases expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | Dimethylnitrosamine results in increased expression of CR1L mRNA | CTD | PMID:15890375 | ozone | multiple interactions | ISO | Cr1l (Mus musculus) | 6480464 | CR1L protein affects the reaction [Ozone results in increased expression of CXCL1 protein] more ... | CTD | PMID:14701711 | panobinostat | increases expression | EXP | | 6480464 | panobinostat results in increased expression of CR1L mRNA | CTD | PMID:26272509 | panobinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CR1L mRNA | CTD | PMID:27188386 | paracetamol | multiple interactions | ISO | Cr1l (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of CR1L mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CR1L mRNA] | CTD | PMID:17585979 | paracetamol | decreases expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of CR1L mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of CR1L mRNA | CTD | PMID:25812627 | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of CR1L mRNA | CTD | PMID:25812627 | piperonyl butoxide | increases expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | Piperonyl Butoxide results in increased expression of CR1L mRNA | CTD | PMID:15890375 | pirinixic acid | increases expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | pirinixic acid results in increased expression of CR1L mRNA | CTD | PMID:15890375 more ... | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of CR1L mRNA | CTD | PMID:29955902 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CR1L mRNA] | CTD | PMID:35811015 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenate | decreases expression | ISO | Cr1l (Mus musculus) | 6480464 | sodium arsenate results in decreased expression of CR1L mRNA | CTD | PMID:30953684 | sodium arsenite | decreases expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | sodium arsenite results in decreased expression of CR1L mRNA | CTD | PMID:19072884 | sulforaphane | increases expression | EXP | | 6480464 | sulforaphane results in increased expression of CR1L mRNA | CTD | PMID:26833863 | Testosterone propionate | multiple interactions | ISO | Cr1l (Mus musculus) | 6480464 | Testosterone Propionate inhibits the reaction [Endosulfan results in decreased expression of CR1L mRNA] | CTD | PMID:25242399 | tetrachloromethane | increases expression | ISO | Cr1l (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of CR1L mRNA | CTD | PMID:31919559 | thapsigargin | increases expression | ISO | Cr1l (Rattus norvegicus) | 6480464 | Thapsigargin results in increased expression of CR1L protein | CTD | PMID:35544339 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of CR1L mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CR1L mRNA | CTD | PMID:27188386 | valproic acid | decreases expression | ISO | Cr1l (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of CR1L mRNA | CTD | PMID:19136453 and PMID:21427059 | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CR1L mRNA | CTD | PMID:27188386 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of CR1L mRNA | CTD | PMID:23179753 more ... | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of CR1L gene | CTD | PMID:29154799 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of CR1L mRNA | CTD | PMID:25979313 | vitamin E | multiple interactions | ISO | Cr1l (Mus musculus) | 6480464 | Vitamin E inhibits the reaction [Endosulfan results in decreased expression of CR1L mRNA] | CTD | PMID:23208437 | water | multiple interactions | ISO | Cr1l (Rattus norvegicus) | 6480464 | [Water deficiency co-treated with Diclofenac] results in decreased expression of CR1L protein and Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in decreased expression of CR1L protein] | CTD | PMID:31042592 | zinc sulfate | multiple interactions | ISO | Cr1l (Mus musculus) | 6480464 | [Zinc Sulfate co-treated with CR1L protein] results in increased expression of C3 protein | CTD | PMID:15086380 | zinc sulfate | increases expression | ISO | Cr1l (Mus musculus) | 6480464 | Zinc Sulfate results in increased expression of CR1L protein | CTD | PMID:15086380 | |